Aktive Positionen von Chulho Park
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | - |
| Gründer | 01.01.2015 | - |
Karriereverlauf von Chulho Park
Ehemalige bekannte Positionen von Chulho Park
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 22.04.2019 | 01.07.2021 |
| Mabprex, Inc. | Vorstandsvorsitzender | 01.01.2010 | 01.01.2018 |
| Gründer | 01.01.2010 | 01.01.2018 | |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Corporate Officer/Principal | 01.01.2013 | 01.09.2013 |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
| Mabprex, Inc. |
- Börse
- Insiders
- Chulho Park
- Erfahrung